Status:
COMPLETED
S(+)-Ibuprofen Effects on Asprin Treated Volunteers
Lead Sponsor:
Gebro Pharma GmbH
Conditions:
Drug Interactions
Eligibility:
All Genders
18-55 years
Phase:
PHASE1
Brief Summary
The purpose of this clinical trial is to determine whether S(+)-ibuprofen affect the platelet inhibition under steady state acetylsalicylic acid conditions.
Eligibility Criteria
Inclusion
- Healthy caucasian volunteer
- Must be able to swallow tablets
Exclusion
- Underlying diseases
- Ulcus pepticum in history
- Abuse of alcoholic beverages (40g/d)
- Hypersensitivity to investigational medicinal products
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
End Date :
October 1 2007
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT00442585
Start Date
September 1 2006
End Date
October 1 2007
Last Update
March 13 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Clinical Pharmacology, Medical University Vienna
Vienna, Vienna, Austria, 1090